SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-000943
Filing Date
2024-05-09
Accepted
2024-05-09 16:06:14
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q g084219_10q.htm   iXBRL 10-Q 651701
2 EXHIBIT 10.1 g084219_ex10-1.htm EX-10.1 182293
3 EXHIBIT 31.1 g084219_ex31-1.htm EX-31.1 12950
4 EXHIBIT 31.2 g084219_ex31-2.htm EX-31.2 13052
5 EXHIBIT 32.1 g084219_ex32-1.htm EX-32.1 8523
6 EXHIBIT 32.2 g084219_ex32-2.htm EX-32.2 8334
  Complete submission text file 0001753926-24-000943.txt   4091130

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE lipo-20240331.xsd EX-101.SCH 35322
8 XBRL CALCULATION FILE lipo-20240331_cal.xml EX-101.CAL 40766
9 XBRL DEFINITION FILE lipo-20240331_def.xml EX-101.DEF 102556
10 XBRL LABEL FILE lipo-20240331_lab.xml EX-101.LAB 264797
11 XBRL PRESENTATION FILE lipo-20240331_pre.xml EX-101.PRE 207759
69 EXTRACTED XBRL INSTANCE DOCUMENT g084219_10q_htm.xml XML 515496
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 24930482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)